Form 4 for GILD Gilead Sciences
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-15 · accession 0000882095-25-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-18 | 2025-08-15 | GILD | Mercier Johanna | Chief Commercial Off | S - Sale+OE | $118.53 | -28.0K | 117.2K | -19% | -$3.32M |
| DM | 2025-08-18 | 2025-08-15 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | $66.64 | +25.0K | 129.0K | +24% | +$1.67M |
| DM | 2025-08-18 | 2025-08-15 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | $0.00 | -25.0K | 98.1K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | S | D | 2,800 | $118.51 | 114,368 | D | — | — | (F4) Sales prices for the transactions reported here range from $117.91 to $118.85. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 2 | Common | Common Stock | 2025-08-15 | S | D | 200 | $118.97 | 114,168 | D | — | — | (F5) Sales prices for the transactions reported here range from $118.95 to $118.98. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 3 | Common | Common Stock | 2025-08-15 | S | D | 700 | $118.97 | 117,168 | D | — | — | (F3) Sales prices for the transactions reported here range from $118.91 to $119.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request. |
| 4 | Common | Common Stock | 2025-08-15 | M | A | 700 | $66.64 | 117,868 | D | — | — | |
| 5 | Common | Common Stock | 2025-08-15 | S | D | 11,800 | $118.51 | 117,168 | D | — | — | (F2) Sales prices for the transactions reported here range from $117.91 to $118.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 6 | Common | Common Stock | 2025-08-15 | M | A | 11,800 | $66.64 | 128,968 | D | — | — | |
| 7 | Common | Common Stock | 2025-08-15 | S | D | 700 | $118.97 | 117,168 | D | — | — | (F3) Sales prices for the transactions reported here range from $118.91 to $119.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or the shareowners upon request. |
| 8 | Common | Common Stock | 2025-08-15 | M | A | 700 | $66.64 | 117,868 | D | — | — | |
| 9 | Common | Common Stock | 2025-08-15 | S | D | 11,800 | $118.50 | 117,168 | D | — | — | (F2) Sales prices for the transactions reported here range from $117.91 to $118.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 10 | Common | Common Stock | 2025-08-15 | M | A | 11,800 | $66.64 | 128,968 | D | — | — | |
| 11 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 11,800 | $0.00 | 111,310 | D | $66.64 · — to 2029-07-24 | 11,800 Common Stock | (F6) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 12 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 700 | $0.00 | 110,610 | D | $66.64 · — to 2029-07-24 | 700 Common Stock | (F6) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 13 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 11,800 | $0.00 | 98,810 | D | $66.64 · — to 2029-07-24 | 11,800 Common Stock | (F6) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 14 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-08-15 | M | D | 700 | $0.00 | 98,110 | D | $66.64 · — to 2029-07-24 | 700 Common Stock | (F6) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |